Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens | Zendy

Licy L. Yanes Cardozo | Zendy; Damián G. Romero | Zendy; Jane F. Reckelhoff | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens

Author(s) -

Licy L. Yanes Cardozo,

Damián G. Romero,

Jane F. Reckelhoff

Publication year - 2017

Publication title -

physiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.14

H-Index - 125

eISSN - 1548-9213

pISSN - 1548-9221

DOI - 10.1152/physiol.00030.2016

Subject(s) - polycystic ovary , endocrine system , endocrinology , medicine , androgen excess , ovary , testosterone (patch) , insulin resistance , physiology , obesity , hormone

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder that affects reproductive-age women. Hyperandrogenemia is present in a significant fraction (~80%) of women with PCOS. Increased prevalence of cardiometabolic risk factors is frequently observed in PCOS women. The present review aims to highlight the key role of androgens in mediating the negative cardiometabolic profile observed in PCOS women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research